Exercise Studies - None at this time
Phone Number: 713-794-5494
Population: English speaking, 21-55 years old, must have access to telephone and/or internet
Brief Description: The goal of this research study is to learn more about the bacteria found in the digestive tract and if these bacteria influence the brain's response to food images and eating behavior .
Phone Number: 713-794-1793
Population: female breast cancer and non-cancer patients, 18 years and older
Brief Description: The goal of this research study is to test Tibetan meditation as a therapy to teach cancer patients to change their brain functioning and to improve quality of life. Researchers want to compare the cancer patients' outcomes to people who have never had cancer.
Phone Number: 713-792-1425
Population: smokers, 18 years or older
Brief Description: The goal of this research study is to learn more about the effects of different nicotine levels in cigarettes. (Note: This is not a smoking cessation study.)
Phone Number: 713-792-1400
Population: adult smokers and heavy drinkers (age 18 years and older) in the Houston metropolitan and surrounding areas
Brief Description: Topiramate has been used to reduce drinking and smoking behavior. The goal of this clinical study is to learn if Topiramate used in both high and low doses increases the percentage of people with no drinking days, while also increasing the rate of smoking abstinence.
Phone Number: 713-794-4763
Population: smokers ages 35-60
Brief Description: The goal of this research study is to learn more about how a smoker's brain responds to cues in their environment and how smoking a cigarette influences brain responses. Brain responses will be measured using a functional magnetic resonance imaging (fMRI) scanner.
Phone Number: 713-792-2265
Population: 18-65 healthy smokers that are interested in treatment that may change their smoking behavior
Brief Description: The goal of this clinical research study is to learn if the combination of the nicotine patch and nicotine lozenge is more effective at helping people to quit smoking or reduce the amount they smoke than Chantix (varenicline). Researchers also want to learn if it is more effective to leave people on their original treatment even if they do not quit smoking versus increasing their treatment dose or switching them to another treatment.